Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Full Paper
  • Published:

Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection

A Corrigendum to this article was published on 05 December 2007

Abstract

The low-density lipoprotein receptor (LDLR) has been proposed to promote hepatitis C virus endocytosis and the cell membrane protein CD81 may also promote HCV host cell entry. The CD81 gene was sequenced to screen for novel polymorphisms, but no SNPs were identified. Polymorphisms within the LDLR gene are associated with the pathogenesis of familial hypercholesterolemia, atherosclerosis and obesity. We therefore studied genetic variation within the LDLR gene and clinical features of hepatitis C infection. An amino acid change in exon 8 was associated with severity of fibrosis; a SNP in exon 10 correlated with viral clearance and overall inflammation, and a SNP in the 3′UTR appeared to influence treatment response. There were no other significant associations between any of the SNPs studied and the clinical measures of hepatitis C infection. We furthermore report on linkage disequilibrium within the gene and haplotype frequencies in our population. Our findings support a possible role for the LDLR in the modulation of disease progression by affecting immune responses, rather than functioning as receptor for HCV.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. WHO. Weekly Epidemiological Record. Record: WHO; 1999 10/12/1999. Report No.: 49

  2. Marcellin P . Hepatitis C: the clinical spectrum of the disease J Hepatol 1999 31 (Suppl 1) : 9–16

    Article  PubMed  Google Scholar 

  3. Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX . Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor Proc Natl Acad Sci USA 1999 96: 12766–12771

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Monazahian M, Bohme I, Bonk S et al. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus J Med Virol 1999 57: 223–229

    Article  CAS  PubMed  Google Scholar 

  5. Pileri P, Uematsu Y, Campagnoli S et al. Binding of hepatitis C virus to CD81 Science 1998 282: 938–941

    Article  CAS  PubMed  Google Scholar 

  6. Hofer F, Gruenberger M, Kowalski H et al. Members of the low density lipoprotein receptor family mediate cell entry of a minorgroup common cold virus Proc Natl Acad Sci USA 1994 91: 1839–1842

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Bates P, Young JA, Varmus HE . A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor Cell 1993 74: 1043–1051

    Article  CAS  PubMed  Google Scholar 

  8. Hobbs HH, Brown MS, Goldstein JL . Molecular genetics of the LDL receptor gene in familial hypercholesterolemia Hum Mutat 1992 1: 445–466

    Article  CAS  PubMed  Google Scholar 

  9. Hussain MM, Strickland DK, Bakillah A . The mammalian low-density lipoprotein receptor family 1999 19: 141–142

  10. Goldstein JL, Brown MS . Familial hypercholesterolemia In: Stanbury JB, Wyngaarden JB, Frederickson DS, Golstein JL, Brown JS (eds) The Metabolic Basis of Inherited Disease. 5th edn McGraw-Hill, New York 1983 p 672–712

    Google Scholar 

  11. Zee RY, Schrader AP, Robinson BG, Griffiths LR, Morris BJ . Association of HincII RFLP of low density lipoprotein receptor gene with obesity in essential hypertensives Clin Genet 1995 47: 118–121

    Article  CAS  PubMed  Google Scholar 

  12. Salazar LA, Hirata MH, Giannini SD et al. Seven DNA polymorphisms at the candidate genes of atherosclerosis in Brazilian women with angiographically documented coronary artery disease Clin Chim Acta 2000 300: 139–149

    Article  CAS  PubMed  Google Scholar 

  13. Feingold KR, Grunfeld C . Lipoproteins: are they important components of host defense? Hepatology 1997 26: 1685–1686

    Article  CAS  PubMed  Google Scholar 

  14. Maecker HT, Todd SC, Levy S . The tetraspanin superfamily: molecular facilitators Faseb J 1997 11: 428–442

    Article  CAS  PubMed  Google Scholar 

  15. Higginbottom A, Quinn ER, Kuo CC et al. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2 J Virol 2000 74: 3642–3649

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Hill AV . Immunogenetics and genomics Lancet 2001 357: 2037–2041

    Article  CAS  PubMed  Google Scholar 

  17. Thursz M, Yallop R, Goldin R, Trepo C, Thomas HC . Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research Lancet 1999 354: 2119–2124

    Article  CAS  PubMed  Google Scholar 

  18. Lauer GM, Walker BD . Hepatitis C virus infection N Engl J Med 2001 345: 41–52

    Article  CAS  PubMed  Google Scholar 

  19. Minuk GY . The influence of host factors on the natural history of chronic hepatitis C viral infections J Viral Hepat 1999 6: 271–276

    Article  CAS  PubMed  Google Scholar 

  20. Thio CL, Thomas DL, Carrington M . Chronic viral hepatitis and the human genome Hepatology 2000 31: 819–827

    Article  CAS  PubMed  Google Scholar 

  21. Thursz M . MHC and the viral hepatitides QJM 2001 94: 287–291

    Article  CAS  PubMed  Google Scholar 

  22. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer zum Buschenfelde KH, Ritner C . Tumor necrosis factor alpha promoter polymorphism at position −238 is associated with chronic active hepatitis C infection J Med Virol 1998 54: 173–177

    Article  CAS  PubMed  Google Scholar 

  23. Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD et al. Host genetic factors influence disease progression in chronic hepatitis C Hepatology 2000 31: 828–833

    Article  CAS  PubMed  Google Scholar 

  24. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE . Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa Hepatology 1999 30: 526–530

    Article  CAS  PubMed  Google Scholar 

  25. Kazemi-Shirazi L, Datz C, Maier-Dobersberger T et al. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C Gastroenterology 1999 116: 127–134

    Article  CAS  PubMed  Google Scholar 

  26. Smith BC, Gorve J, Guzail MA et al. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C Hepatology 1998 27: 1695–1699

    Article  CAS  PubMed  Google Scholar 

  27. Hezode C, Cazeneuve C, Coue O et al. Hemochromatosis Cys282Tyr mutation and liver iron overload in patients with chronic active hepatitis C Hepatology 1998 27: 306

    Article  CAS  PubMed  Google Scholar 

  28. Poynard T, Bedossa P, Opolon P . Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups Lancet 1997 349: 825–832

    Article  CAS  PubMed  Google Scholar 

  29. Atanassov N, Markova V, Boev T, Keremidtchieva T, Vladimirova L, Djurdjev A . LDL-receptor gene polymorphism in patients with early-onset coronary artery disease Folia Med 1998 40: 5–10

    CAS  Google Scholar 

  30. Scholtz CL, Zeier M, Engelbrecht S, Van Rensburg EJ, Kotze MJ . Polymorphisms in the promoter region of the LDL receptor gene: a possible role in disease progression of HIV-infected patients. The XIII international AIDS conference 2000

  31. Miserez AR, Schuster H, Chiodetti N, Keller U . Polymorphic haplotypes and recombination rates at the LDL receptor gene locus in subjects with and without familial hypercholesterolemia who are from different populations Am J Hum Genet 1993 52: 808–826

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Daga A, Mattioni T, Balestreri R, Coviello DA, Corte G, Bertolini S . Use of three DNA polymorphisms of the LDL receptor gene in the diagnosis of familial hypercholesterolemia Hum Genet 1990 84: 412–416

    Article  CAS  PubMed  Google Scholar 

  33. Chaves FJ, Puig O, Garcia-Sogo M et al. Seven DNA polymorphisms in the LDL receptor gene: application to the study of familial hypercholesterolemia in Spain Clin Genet 1996 50: 28–35

    Article  CAS  PubMed  Google Scholar 

  34. Gudnason V, Patel D, Sun XM, Humphries S, Soutar AK, Knight BL . Effect of the Stul polymorphism in the LDL receptor gene (Ala 370 to Thr) on lipid levels in healthy individuals Clin Genet 1995 47: 68–74

    Article  CAS  PubMed  Google Scholar 

  35. Yamaki E, Hirayama T, Wu LL, Hopkins PN, Williams RR, Emi M . Molecular genetic diagnosis of a family with hypercholesterolemia by a mismatched PCR-RFLP method for genotyping single base substitution of the LDL receptor gene Jpn Heart J 1998 39: 681–686

    Article  CAS  PubMed  Google Scholar 

  36. Poledne R, Pisa Z, Berg K . Normal genetic variation at the low density lipoprotein receptor (LDLR) locus influences cholesterol levels in children Clin Genet 1993 43: 122–126

    Article  CAS  PubMed  Google Scholar 

  37. Pongrapeeporn KU, Pimsawat T, Likidlilid A et al. Effect of Ava II and Ncol polymorphisms at the low density lipoprotein receptor gene on plasma lipid levels in a group of Thai subjects J Med Assoc Thai 2000 83 (Suppl 2) : S74–S80

    PubMed  Google Scholar 

  38. Agnello V, Abel G . Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia Arthritis Rheum 1997 40: 2007–2015

    Article  CAS  PubMed  Google Scholar 

  39. Seipp S, Mueller HM, Pfaff E, Stremmel W, Theilmann L, Goeser T . Establishment of persistent hepatitis C virus infection and replication in vitro J Gen Virol 1997 78: 2467–2476

    Article  CAS  PubMed  Google Scholar 

  40. Enjoji M, Nakamuta M, Kinukawa N et al. Betalipoproteins influence the serum level of hepatitis C virus Med Sci Monit 2000 6: 841–844

    CAS  PubMed  Google Scholar 

  41. Meyer K, Basu A, Ray R . Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells Virology 2000 276: 214–226

    Article  CAS  PubMed  Google Scholar 

  42. Jones IM, Chan-Fook C, Jiang WR, Clarke BE . Receptors for hepatitis C virus J Virol 2000 74: 10860–10861

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Fischer DG, Novick D, Cohen B, Rubinstein M . Isolation and characterization of a soluble form of the LDL receptor, an interferon-induced antiviral protein Proc Soc Exp Biol Med 1994 206: 228–232

    Article  CAS  PubMed  Google Scholar 

  44. Rensen PCN, van Oosten M, van de Bilt E, van Eck M, Kuiper J, van Berkel TJC . Lipoprotiens: are they important in components of host defense? J Clin Invest 1997 99: 2438–2445

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Netea MG, Demacker PN, Kullberg BJ et al. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections J Clin Invest 1996 97: 1366–1372

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Bellosta S, Mahley RW, Sanan DA et al. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice J Clin Invest 1995 96: 2170–2179

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Ludewig B, Jaggi M, Dumrese T et al. Hypercholesterolemia exacerbates virus-induced immunopathologic liver disease via suppression of antiviral cytotoxic T cell responses J Immunol 2001 166: 3369–3376

    Article  CAS  PubMed  Google Scholar 

  48. Masciopinto F, Campagnoli S, Abrignani S, Uematsu Y, Pileri P . The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptor Virus Res 2001 80: 1–10

    Article  CAS  PubMed  Google Scholar 

  49. Itakura J, Nagayama K, Enomoto N et al. CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection J Med Virol 2001 63: 22–28

    Article  CAS  PubMed  Google Scholar 

  50. Petracca R, Falugi F, Galli G et al. Structure-function analysis of hepatitis C virus envelope-CD81 binding J Virol 2000 74: 4824–4830

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Kumar A, Middleton A, Chambers TC, Mehta KD . Differential roles of extracellular signal-regulated kinase-1/2 and p38(MAPK) in interleukin-1 beta- and tumor necrosis factor-alpha-induced low density lipoprotein receptor expression in HepG2 cells J Biol Chem 1998 273: 15742–15748

    Article  CAS  PubMed  Google Scholar 

  52. Dinarello CA . Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist Int Rev Immunol 1998 16: 457–499

    Article  CAS  PubMed  Google Scholar 

  53. Huang Y, Blatt LM, Taylor MW . Type 1 interferon as an antiinflammatory agent: inhibition of lipopolysaccharide-induced interleukin-1 beta and induction of interleukin-1 receptor antagonist J Interferon Cytokine Res 1995 15: 317–321

    Article  CAS  PubMed  Google Scholar 

  54. Tilg H, Mier JW, Vogel W et al. Induction of circulating IL-1 receptor antagonist by IFN treatment J Immunol 1993 150: 4687–4692

    CAS  PubMed  Google Scholar 

  55. Ishak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis J Hepatol 1995 22: 696–699

    Article  CAS  PubMed  Google Scholar 

  56. Day DJ, Speiser PW, White PC, Barany F . Detection of steroid 21-hydroxylase alleles using gene-specific PCR and a multiplexed ligation detection reaction Genomics 1995 29: 152–162

    Article  CAS  PubMed  Google Scholar 

  57. Abecasis GR, Cookson WO . GOLD-graphical overview of linkage disequilibrium Bioinformatics 2000 16: 182–183

    Article  CAS  PubMed  Google Scholar 

  58. Stephens M, Smith NJ, Donnelly P . A new statistical method for haplotype reconstruction from population data Am J Hum Genet 2001 68: 978–989

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank the patients for their cooperation and participation in this study. Special thanks go to Kevin Bottomley and Jonathan Sheldon for their support throughout and to Patty Ramaley for providing the promoter SNP LDR probes.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A V S Hill.

Additional information

This work was funded by Roche Discovery, Welwyn, UK. AV Hill is a Wellcome Trust Principal Research Fellow. Dr Mark Wright was funded by the Medical Research Council.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hennig, B., Hellier, S., Frodsham, A. et al. Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection. Genes Immun 3, 359–367 (2002). https://doi.org/10.1038/sj.gene.6363883

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gene.6363883

Keywords

This article is cited by

Search

Quick links